Biaera AeroMP暴露评价系统发表的文献

以下为节选的Biaera AeroMP暴露评价系统发表在高水平杂志的文献。

如： Journal of Virology，Infection and Immunity，Journal of Immunology，Pathogens and Disease，Proceedings of the National Academy of Sciences，PloS One

• 2014
•  
• DS Reed, PJ Glass, RR Bakken, JF Barth, DM Lind, MK Hart, J Rayner, K Alterson, M Custer, J Dudek, G Owens, KI Kamrud, MD Parker, and J Smith, “Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitic viruses,” Journal of Virology, in press (2014).
•  
• DS Reed, L Smith, KS Cole, AE Santiago, BJ Mann, and EM Parry, “Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain,” Infection and Immunity 82(2):2098 (2014).
•  
• AL Caroline, DS Powell, LM Bethel, TD Oury, DS Reed, and AL Hartman, “Broad spectrum antiviral activity of Favipiravir (T-705): Protection from highly lethal inhalational Rift Valley Fever in Wistar-Furth rats,” PLoS Negl. Trop. Dis. 8(4): e2790, (2014).
•  
• JA Belser, KM Gustin, JM Katz, TR Maines, and TM Tumpey, “Influenza virus infectivity and virulence following ocular-only aerosol inoculation of ferrets,” Journal of Virology 88(17), 9647 (2014).
•  
• JS Woodworth, CS Aagaard, PR Hansen, JP Cassidy, EM Agger, and P Andersen, “Protective CD4 T Cells Targeting Cryptic Epitopes of Mycobacterium tuberculosis Resist Infection-Driven Terminal Differentiation,” Journal of Immunology, 192(7):3247-58 (2014).
•  
• PB Jahrling, L Keith, M St. Claire, RF Johnson, L Bollinger, MG Lackemeyer, LE Hensley, J Kindrachuk, and JH Kuhn, “The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens,” Pathogens and Disease, 17:211 (2014).
•  
• MV Bianco, S Clark, FC Blanco, S Garbaccio, E Garcia, AA Cataldi, A Williams, and F Bigi, “Assessment of Mycobacterium bovis Deleted in p27-p55 Virulence Operon as Candidate Vaccine against Tuberculosis in Animal Models,” BioMed Research International 2014, article ID 951978, (2014).
•  
• NPH Knudsen, S Norskov-Lauritsen, GM Dolganov, GK Schoolnik, T Lindenstrom, P Andersen, EM Agger, and C Aagaard, “Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics,” Proceedings of the National Academy of Sciences, doi10:1073/pnas.1314973111 (2014).
•  
• AL Hartman, DS Powell, LM Bethel, AL Caroline, RJ Schmid, T Oury, and DS Reed, “Aerosolized Rift Valley Fever Virus Causes Fatal Encephalitis in African Green Monkeys and Common Marmosets,” Journal of Virology, 88:2235 (2014).
•  
• S Massey, LA Yeager, CA Blumentritt, S Vijayakumar, E Sabrana, JW Peterson, T Brasel, JW LeDuc, JJ Endsley, and AG Torres, “Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection,” Scientific Reports, 4:4305, doi:10.1038/srep04305 (2014).
•  
• MG Lackemeyer, F de Kok-Mercado, J Wada, L Bollinger, J Kindrachuk, V Wahl-Jensen, JH Huhn, and PB Jahrling, “ABSL-4 Aerobiology Biosafety and Technology at the NIH/NIAID Integrated Research Facility at Fort Detrick,” Viruses 6:137-150; doi:10.3390/v6010137 (2014).
•  
• DS Reed, LM Bethel, DS Powell, AL Caroline, and AL Hartman, “Differences in aerosolization of Rift Valley fever virus resulting from choice of inhalation exposure chamber: implications for animal challenge studies,” Pathogens and Disease, 0:1 (2014).
•  
• HC Poyntz, E Stylianou, KL Griffiths, L Marsay, AM Checkley, and H McShane, “Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis,” Tuberculosis 94(1);1-12 (2014).
•  
• 2013
•  
• KM Lee, KB Chiu, HA Sansling, PJ Didier, TA Ficht, AM Arenas-Gamboa, CJ Roy, and AG MacLean, “Aerosol-induced brucellosis increases TLR-2 expression and increased complexity in the microanatomy of astroglia in rhesus macaques,” Frontiers in Cellular and Infection Micobiology, doi:10.3389/fcimb.2013.00086 (2013).
•  
• KM Gustin, JM Katz, TM Tumpey, and TR Maines, “Comparison of levels of infectious virus in respirable aerosols exhaled by ferrets infected with influenza viruses exhibiting diverse transmissibility phenotypes,” Journal of Virology, 87, 7864 (2013).
•  
• KL Griffiths, E Stylianou, HC Poyntz, GJ Betts, HA Fletcher, and H McShane, “Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice,” PloS One 8(10), (2013).
•  
• N van Doremalen, T Bushmaker, and VJ Munster, “Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions,” European Surveillance, 18(39), pii 20590 (2013).
•  
• L Marsay, M Matsumiya, R Tanner, H Poyntz, KL Griffiths, E Stylianou, PD Marsh, A Williams, S Sharpe, H Fletcher, and H McShane, “Mycobaterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis,” Tuberculosis 93(5): 551-7 (2013).
•  
• DJ Springer, D Saini, EJ Byrnes, J Heitman, and R Frothingham, “Development of an aerosol model of Cryptococcus reveals humidity as an important factor affecting the viability of Cryptococcus during aerosolization,” PLoS One 8(7) e69804 (2013).
•  
• E deWit, J Prescott, L Baseler, T Bushmaker, T Thomas, MG Lackemeyer, C Martellaro, S Milne-Price, E Haddock, BL Haagmans, H Feldmann, VJ Munster, “The Middle East Respiratory Syndrome Coronavirus) MERS-CoV Does Not Replicate in Syrian Hamsters,” PLoS One 8(7) e69127 (2013).
•  
• M Bhaskaran, PJ Didier, SK Sivasubramani, LA Doyle, J Holley, and CJ Roy, “Pathology of lethal and sublethal doses of aerosolized ricin in rhesus macaques,” Toxicologic Pathology, 00:1 (2013).
•  
• 2012
•  
• AC Shurtleff, N Garza, M Lackemeyer, R Carrion, A Griffiths, J Patterson, SS Edwin, and S Bavari, “The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment,” Viruses 4:3932 (2012).
•  
• SA Faith, LP Smith, AS Swatland, and DS Reed, “Growth conditions and environmental factors impact aerosolization but not virulence of Fracisella tularensis infection in mice,” Frontiers in Cellular and Infection Microbiology, doi:10.3389/fcimb.2012.00126 (2012).
•  
• JM Bales, DS Powell, LM Bethel, DS Reed, and AL Hartman, “Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus,” Frontiers in Cellular and Infection Microbiology, doi:10.3389/fcimb.2012.00105 (2012).
•  
• D Saini, GW Hopkins, SA Sea, CJ Chen, CC Perley, EM Click, and R Frothingham, “Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice,” Tuberculosis 92:160 (2012).
•  
• 2011
•  
• KM Gustin, JA Belser, DA Wadford, MB Pearce, JM Katz, TM Tumpey, and TR Maines, “Influenza virus aerosol exposure and analytical system for ferrets,” Proceedings of the National Academy of Science, doi:10.1073/pnas.1100768108 (2011).
•  
• DS Reed, L Smith, T Dunsmore, A Trichel, LA Ortiz, KS Cole, and E Barry, “Pneumonic Tularemia in Rabbits Resembles the Human Disease as Illustrated by Radiographic and Hematological Changes after Infection,” PLoS One 6(9): e24654. doi:10.1371/journal.pone.0024654 (2011).
•  
• D Saini, GW Hopkins, C Chen, SA Seay, EM Click, S Lee, JM Hartings, and R Frothingham, “Sampling port for real-time analysis of bioaerosol in whole body exposure system for animal aerosol model development,” Journal of Pharmacological and Toxicological Methods 63:143 (2011).
•  
• DE Williamson, AJ Simpson, EL Waters, PJ Packer, ML Pitt, JM Hartings, D Dyer, and NA Twenhafel, “Recombinant (F1+V) vaccine protects cynomologus macaques against pneumonic plague,” Vaccine 29:4771 (2011).
•  
• 2010
•  
• A Nalca, VA Livingston, NL Garza, EE Zumbrun, OM Frick, JL Chapman, and JM Hartings, “Experimental infection of Cynomologus Macaques (Macaca fascicularis) with aerosolized Monkeypox Virus,” PLoS One, 5:e12880 (2010).
•  
• P Fellows, J Adamovicz, JM Hartings, R Sherwood, W Mega, T Brasel, E Barr, L Holland, W Lin, A Rom, W Blackwelder, J Price, S Morris, D Snow, and MK Hart, “Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V),” Vaccine, 28:7748 (2010).